Effects of the chiral isomers of erythro- and threo-9-(2-hydroxy-3-nonyl)adenine on purine metabolism in sarcoma 180 cells
- 1 December 1982
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 31 (24) , 3955-3960
- https://doi.org/10.1016/0006-2952(82)90641-4
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Effect of chirality in erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) on adenosine deaminase inhibitionBiochemical Pharmacology, 1982
- Adenosine deaminase inhibitors. Conversion of a single chiral synthon into erythro- and threo-9-(2-hydroxy-3-nonyl)adeninesJournal of Medicinal Chemistry, 1981
- The interaction of inhibitors with adenosine metabolising enzymes in intact isolated cellsBiochemical Pharmacology, 1981
- The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancyBlood, 1981
- The clinical pharmacology of the adenosine deaminase inhibitor 2?-deoxycoformycinCancer Chemotherapy and Pharmacology, 1980
- Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in miceAntimicrobial Agents and Chemotherapy, 1980
- Specificity of adenosine deaminase inhibitorsBiochemical Pharmacology, 1977
- Tight-binding inhibitors—IV. Inhibition of adenosine deaminases by various inhibitorsBiochemical Pharmacology, 1977
- Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adeninesJournal of Medicinal Chemistry, 1974
- Inhibition of purine biosynthesis de novo in sarcoma 180 ascites cells by mercapto and seleno purine analogsBiochemical Pharmacology, 1973